Rapid Dose Therapeutics Corp. RDTCF

RDTCF Company Overview

Rapid Dose Therapeutics Corp. (traded on the Canadian Securities Exchange under the symbol DOSE) is a Canadian biotechnology and pharmaceutical delivery company focused on oral fast-dissolving drug delivery technologies. The company develops and commercializes proprietary oral thin-film products designed to deliver active pharmaceutical ingredients, nutraceutical compounds, cannabinoids, and other bioactive substances through rapid oral absorption. Rapid Dose Therapeutics operates primarily within the pharmaceutical delivery, cannabis wellness, and nutraceutical industries, with its core commercial platform centered on the company’s QuickStrip™ technology.

The company’s principal business model is based on licensing, manufacturing, and commercializing oral thin-film delivery products for both domestic and international markets. Rapid Dose Therapeutics has pursued partnerships with cannabis producers, pharmaceutical groups, and distribution companies to expand the use of its delivery platform across multiple therapeutic and wellness categories. Public disclosures and corporate materials indicate that the company positions its technology as an alternative to traditional capsules, edibles, and inhalation-based delivery methods due to portability, dosage precision, and faster onset characteristics. Rapid Dose Therapeutics evolved from a cannabis-focused oral delivery developer into a broader drug-delivery technology company seeking applications in healthcare, wellness, and pharmaceutical sectors.